With deep experience in European growth capital, the managers have executed over 40 deals across technology and life sciences. Their track record highlights a strong focus on scaling later-stage companies, delivering notable exits across healthcare and digital platforms. Recognized for structured financing expertise, they emphasize operational improvements to drive sustainable long-term value creation.